Japan· JP-3999024M1042
ジアゾキシド
A diazoxide product containing ジアゾキシド, registered in Japan by オーファンパシフィック, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Diazoxide is registered in 5 of 19 countries.
Countries holding a registration under ATC C02DA01 (diazoxide), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 2 of them publish a price we can compare per daily dose
Diazoxide · ATC C02DA01
5 / 19 countries
- Finlandprice
- Germany
- Japan
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ジアゾキシド
- Manufacturer
- オーファンパシフィック
- Country
- Japan (JP)
- ATC code
- C02DA01
- ATC class
- Diazoxide
- Defined daily dose
- 0.3 g, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
248 interactions on record for diazoxide.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Diazoxide · interactions on record
248 records
- 1 severe
- 243 moderate
- 4 minor
Most severe, free to view
- TizanidineM03BX02severe
- DimenhydrinatA04AB02moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Diazoxide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDiazoxide 100mg capsulesSpecial Order
- United StatesDiazoxidee5 Pharma, LLC
- NorwayProglicemMSD
- FrancePROGLICEM 100 mg, géluleMSD FRANCE
- ItalyPROGLICEM*100 cps 100 mgMSD ITALIA Srl
- GermanyProglicemMsd Sharp & Dohme Gmbh
- NetherlandsProglicem, capsules 100 mgMerck Sharp & Dohme B.V.
- SwitzerlandProglicem, KapselnMSD Merck Sharp & Dohme AG
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Proglicem
- France · Proglicem
- United Kingdom (Northern Ireland) · Eudemine
- Italy · Proglicem
- Netherlands · Proglicem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4acae190-385e-4896-94a6-79c630e81aab GET /v1/drugs/4acae190-385e-4896-94a6-79c630e81aab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２５ｍｇ１カプセル",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999024M1042",
"category": "内用薬",
"price_yen": 176,
"generic_name": "ジアゾキシド",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about diazoxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.